STRATA Skin Sciences Inc reports results for the quarter ended December 31 - Earnings Summary

• STRATA Skin Sciences Inc SSKN.OQ reported a quarterly adjusted loss of $1.13​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of $-1.10. The mean expectation of two analysts for the quarter was for a loss of 30 cents per share. Wall Street expected results to range from -40 cents to -20 cents per share.

• Revenue rose 54.3% to $9.58 million from a year ago; analysts expected $8.97 million.

• STRATA Skin Sciences Inc's reported EPS for the quarter was a loss of $1.13​.

• The company reported a quarterly loss of $4.49 million.

• STRATA Skin Sciences Inc shares had fallen by 10.3% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 24.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

• Wall Street's median 12-month price target for STRATA Skin Sciences Inc is $11.00

This summary was machine generated from LSEG data March 27 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)